本文旨在构建有效抑制朊蛋白(Prion protein,PrP)表达的重组质粒,并以此为工具控制PrP表达,从而探讨PrP对细胞SOD活性的影响。设计并化学合成1对含有发夹结构的寡核苷酸片段(shPrP),退火后与表达载体pG-super(Hairpin siRNA expressing vector)定向连接,构建重组质粒pG-super-shPrP。对重组子进行PCR鉴定,测序正确后,脂质体法转染C6细胞,采用实时荧光定量RT-PCR检测PrP mRNA的表达水平,以验证pG-super-shPrP的抑制效率;结果表明:重组质粒pG-super-shPrP构建成功,且显著降低C6细胞PrP mRNA表达(P〈0.05),抑制效率为34.2%。利用pG-super、pG-super-shPrP分别转染C6细胞,并检测细胞SOD总活性及SOD表达水平,探讨PrP对细胞SOD活性的影响及其作用机制,结果表明PrP促进细胞SOD的活性(P〈0.01),但对细胞SOD的表达量无影响,即PrP对SOD活性的促进作用与SOD1的表达量无关。本研究在成功构建了PrP的RNA干扰表达质粒的基础上,利用此质粒,在细胞水平上揭示了PrP对细胞SOD活性的促进作用。
In present research,we intend to construct pG-super-siPrP expression plasmid and explore its function in C6 cells, shPrP was subcloned into pG-super. Recombinant plasmid pG-super-shPrP was transformed into Topl0 E. coli, and the ampicillin resistant clones were identified by PCR and DNA sequencing. C6 cells were transfected with the identified pG-super-shPrP and pG-super (the control group) by LipofectamineTM 2000. PrP mRNA was quantified by real-time RT-PCR. The results showed that the expression of PrP mRNA in pG-super-shPrP group decreased by 34.2% compared with the control group (P〈0. 05). The detection results of the total activity of superoxide dismutase indicated that PrP promoted the SOD activity. In conclusion, pG- super-shPrP expression plasmid was constructed effectively and took effect in C6 cells, which helped to further study about PrP biochemical and physiological role in animal and offer a attractive therapeutic approach to fight against prion disease.